Author:
Helmink Beth,Wargo Jennifer A
Funder
National Institutes of Health
MD Anderson Cancer Center support grant
Reference10 articles.
1. Prognostic factors analysis of 17 600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system;Balch;J Clin Oncol,2001
2. Targeted agents and immunotherapies: optimizing outcomes in melanoma;Luke;Nat Rev Clin Oncol,2017
3. The new era of adjuvant therapies for melanoma;Eggermont;Nat Rev Clin Oncol,2018
4. Improved efficacy of neoadjuvant compared to adjuvant immunotherapy to eradicate metastatic disease;Liu;Cancer Discov,2016
5. Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB–C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial;Long;Lancet Oncol,2019
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献